MDT · News · 20260910N

Guidance / Outlook

Medtronic plc · 2026-09-10 · Importance 47 · Surprise 60

Medtronic reportedly raised its guidance following strong first-quarter fiscal 2027 results. The update indicates management expects continued organic revenue growth during fiscal 2027. The digest does not provide the revised guidance range or quantify its expected effect on revenue, margins, or cash flow.

Key facts

• Medtronic raised guidance following its recent strong Q1 fiscal year 2027 performance. source
• Medtronic faces challenges with operating margins and competition in the robotic surgery market. source
• Analysts maintain a "Moderate Buy" rating on Medtronic with an average price target of $103.92. source